BACKGROUND: The impact of incomplete revascularization (IR) on adverse outcomes after percutaneous coronary intervention remains inconclusive, and few studies have examined mortality during follow-ups longer than 5 years. The objective of this study is to test the hypothesis that IR is associated with higher risk of long-term (8-year) mortality after stenting for multivessel coronary disease. METHODS AND RESULTS: A total of 13 016 patients with multivessel disease who had undergone stenting procedures with bare metal stents in 1999 to 2000 were identified in the New York State's Percutaneous Coronary Intervention Reporting System. A logistic regression model was fit to predict the probability of achieving complete revascularization (CR) in these patients using baseline risk factors; then, the CR patients were matched to the IR patients with similar likelihoods of achieving CR. Each patient's vital status was followed through 2007 using the National Death Index, and the difference in long-term mortality between IR and CR was compared. It was found that CR was achieved in 29.2% (3803) of the patients. For the 3803 pair-matched patients, the respective 8-year survival rates were 80.8% and 78.5% for CR and IR (P=0.04), respectively. The risk of death was marginally significantly higher for IR (hazard ratio=1.12; 95% confidence interval, 1.01-1.26, P=0.04). The 95% bootstrap confidence interval for the hazard ratio was 0.98 to 1.32. CONCLUSIONS: IR may be associated with higher risk of long-term mortality after stenting with BMS in patients with multivessel disease. More prospective studies are needed to further test this association.
BACKGROUND: The impact of incomplete revascularization (IR) on adverse outcomes after percutaneous coronary intervention remains inconclusive, and few studies have examined mortality during follow-ups longer than 5 years. The objective of this study is to test the hypothesis that IR is associated with higher risk of long-term (8-year) mortality after stenting for multivessel coronary disease. METHODS AND RESULTS: A total of 13 016 patients with multivessel disease who had undergone stenting procedures with bare metal stents in 1999 to 2000 were identified in the New York State's Percutaneous Coronary Intervention Reporting System. A logistic regression model was fit to predict the probability of achieving complete revascularization (CR) in these patients using baseline risk factors; then, the CRpatients were matched to the IR patients with similar likelihoods of achieving CR. Each patient's vital status was followed through 2007 using the National Death Index, and the difference in long-term mortality between IR and CR was compared. It was found that CR was achieved in 29.2% (3803) of the patients. For the 3803 pair-matched patients, the respective 8-year survival rates were 80.8% and 78.5% for CR and IR (P=0.04), respectively. The risk of death was marginally significantly higher for IR (hazard ratio=1.12; 95% confidence interval, 1.01-1.26, P=0.04). The 95% bootstrap confidence interval for the hazard ratio was 0.98 to 1.32. CONCLUSIONS: IR may be associated with higher risk of long-term mortality after stenting with BMS in patients with multivessel disease. More prospective studies are needed to further test this association.
Authors: Marcel J B M van den Brand; Benno J W M Rensing; Marie-angèle M Morel; David P Foley; Vincent de Valk; Arno Breeman; Harry Suryapranata; Maximiliaan M P Haalebos; William Wijns; Francis Wellens; Rafael Balcon; Patrick Magee; Expedito Ribeiro; Enio Buffolo; Felix Unger; Patrick W Serruys Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: G Mariani; S De Servi; A Dellavalle; S Repetto; S Chierchia; M D'Urbano; A Repetto; C Klersy Journal: Catheter Cardiovasc Interv Date: 2001-12 Impact factor: 2.692
Authors: Alexander J J Ijsselmuiden; JanPaul Ezechiels; Iris C D Westendorp; Jan G P Tijssen; Ferdinand Kiemeneij; Ton Slagboom; Ron van der Wieken; GeertJan Tangelder; Patrick W Serruys; GertJan Laarman Journal: Am Heart J Date: 2004-09 Impact factor: 4.749
Authors: D P Faxon; K Ghalilli; A K Jacobs; N A Ruocco; E M Christellis; M A Kellett; T R Varrichione; T J Ryan Journal: Am Heart J Date: 1992-04 Impact factor: 4.749
Authors: M J Cowley; M Vandermael; E J Topol; P L Whitlow; L S Dean; T M Bulle; S G Ellis Journal: J Am Coll Cardiol Date: 1993-11-01 Impact factor: 24.094
Authors: M G Vandormael; B R Chaitman; T Ischinger; U T Aker; M Harper; J Hernandez; U Deligonul; H L Kennedy Journal: J Am Coll Cardiol Date: 1985-11 Impact factor: 24.094
Authors: Edward L Hannan; Ye Zhong; Peter B Berger; Alice K Jacobs; Gary Walford; Frederick S K Ling; Ferdinand J Venditti; Spencer B King Journal: JAMA Cardiol Date: 2018-02-01 Impact factor: 14.676
Authors: Chuntao Wu; Anne-Marie Dyer; Gary Walford; David R Holmes; Spencer B King; Nicholas J Stamato; Samin Sharma; Alice K Jacobs; Ferdinand J Venditti; Edward L Hannan Journal: Am J Cardiol Date: 2013-06-04 Impact factor: 2.778
Authors: S Rasoul; V van Ommen; J Vainer; M Ilhan; L Veenstra; R Erdem; L A W Ruiters; R Theunissen; J C A Hoorntje Journal: Neth Heart J Date: 2015-04 Impact factor: 2.380
Authors: Vinayak Nagaraja; Sze-Yuan Ooi; James Nolan; Adrian Large; Mark De Belder; Peter Ludman; Rodrigo Bagur; Nick Curzen; Takashi Matsukage; Fuminobu Yoshimachi; Chun Shing Kwok; Colin Berry; Mamas A Mamas Journal: J Am Heart Assoc Date: 2016-12-16 Impact factor: 5.501